Chesapeake Asset Management’s AbbVie ABBV Stock Holding History

Chesapeake Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.45M	Buy	5,763 +107	+2%	+$23K	1.11%	18
2026 Q1	$1.23M	Sell	5,656 -911	-14%	-$202K	0.98%	22
2025 Q4	$1.5M	Buy	6,567 +6	+0.1%	+$1.37K	1.24%	17
2025 Q3	$1.52M	Sell	6,561 -104	-2%	-$21.2K	1.34%	17
2025 Q2	$1.24M	Hold	6,665	–	–	1.11%	22
2025 Q1	$1.4M	Buy	6,665 +249	+4%	+$48.4K	1.31%	19
2024 Q4	$1.14M	Sell	6,416 -54	-0.8%	-$9.93K	1.06%	23
2024 Q3	$1.28M	Buy	6,470 +98	+2%	+$18.3K	1.11%	23
2024 Q2	$1.09M	Sell	6,372 -201	-3%	-$33.3K	1.04%	25
2024 Q1	$1.2M	Sell	6,573 -6,436	-49%	-$1.11M	1.18%	24
2023 Q4	$2.02M	Sell	13,009 -542	-4%	-$79K	1.8%	13
2023 Q3	$2.02M	Buy	13,551 +2,321	+21%	+$341K	1.96%	12
2023 Q2	$1.51M	Buy	11,230 +1,478	+15%	+$217K	1.37%	18
2023 Q1	$1.55M	Buy	+9,752	New	+$1.49M	1.42%	18

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Chesapeake Asset Management's ABBV Position: Q2 2026 in Review

Chesapeake Asset Management increased its AbbVie (ABBV) stake by 1.9% in Q2 2026, buying an estimated $23K and bringing the position to 5,763 shares worth $1.45M. The position accounts for 1.11% of the portfolio, ranked #18.

Chesapeake Asset Management first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.02M in Q3 2023. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Chesapeake Asset Management held 5,763 shares of AbbVie worth $1.45M as of Q2 2026.
Chesapeake Asset Management bought 107 AbbVie shares in Q2 2026, an estimated $23K.
AbbVie made up 1.11% of Chesapeake Asset Management's portfolio in Q2 2026, its #18 holding.
Chesapeake Asset Management first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
Chesapeake Asset Management's AbbVie position peaked at $2.02M in Q3 2023.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Chesapeake Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.